SUJANU Combination Tablets [Brand Name]
Sujanu is a medication containing sitagliptin phosphate hydrate and ipragliflozin L-Proline, used for treating type 2 diabetes by improving blood glucose control.
- The description claims that the medicine inhibits enzyme degradation of incretin and enhances insulinotropic action.
- The description claims that the medicine inhibits SGLT2 to excrete excess glucose into urine.
- The description claims that the medicine is used to treat type 2 diabetes.
Specifications
- SHEET
- 1 sheet (10 tablets), 10 sheets (100 tablets)
Variants (2)
- 1 sheet (10 tablets) — 7257.00 JPY — Out of stock
- 10 sheets (100 tablets) — 58056.00 JPY — Out of stock
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
78%